Euretina Congress

BARCELONA, Spain — A post hoc analysis of PULSAR trial data showed sustained fluid control at 2 years with fewer injections and longer dosing intervals in patients treated with aflibercept 8 mg for wet age-related macular degeneration.

BARCELONA, Spain — In the phase 2 ARCHER trial, ANX007, a novel C1q inhibitor with neuroprotective properties, showed consistent protection against loss of visual acuity in eyes with geographic atrophy.

BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Matteo Forlini, MD, discusses a Vit-Buckle Society session on surgical challenges.

BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Paulo-Eduardo Stanga, MD, speaks in favor of treating vitreous floaters and opacities.

BARCELONA, Spain – In this Healio Video Perspective from the Euretina congress, David Wong, MD, shares his thoughts on the advantages of new drugs for retinal conditions including age-related macular degeneration.

BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Jordi Monés, MD, PhD, discusses an investigational optogenetic therapy for geographic atrophy.

BARCELONA, Spain – In this Healio Video Perspective from the Euretina congress, Tien Yin Wong, MD, shares his thoughts on the emerging role of AI in retina.

BARCELONA, Spain – In this Healio Video Perspective at the Euretina congress, Baruch D. Kuppermann, MD, PhD, delivers an overview of new compounds currently under investigation for dry age-related macular degeneration.

BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Sundaram Natarajan, MD, shares his experience with wide-angle viewing systems.

BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Michael W. Stewart, MD, shares his experience with Eylea HD in neovascular age-related macular degeneration and diabetic macular edema.